从算法到生物标志物：迈向静脉血栓栓塞的个性化管理
From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism.
作者信息
Boccatonda Andrea
机构信息
Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
出版信息
J Clin Med. 2025 Sep 1;14(17):6172. doi: 10.3390/jcm14176172.
Abstract
Pulmonary embolism (PE) and venous thromboembolism (VTE) remain major contributors to global morbidity and mortality, yet their management has evolved significantly in recent years [...].
摘要
肺栓塞（PE）和静脉血栓栓塞症（VTE）仍然是全球发病率和死亡率的主要原因，然而近年来它们的治疗方法已经有了显著的发展[...]。
相似文献
1
From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism.
J Clin Med. 2025 Sep 1;14(17):6172. doi: 10.3390/jcm14176172.
2
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023.
Thromb Res. 2025 Jul;251:109337. doi: 10.1016/j.thromres.2025.109337. Epub 2025 May 8.
3
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
4
Pentasaccharides for the prevention of venous thromboembolism.
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
5
Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial.
JMIR Res Protoc. 2025 Jun 5;14:e67254. doi: 10.2196/67254.
6
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
7
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Cochrane Database Syst Rev. 2015 Mar 6(3):CD010837. doi: 10.1002/14651858.CD010837.pub2.
8
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
9
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients.
Cochrane Database Syst Rev. 2008 Oct 8(4):CD005258. doi: 10.1002/14651858.CD005258.pub2.
10
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
本文引用的文献
1
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel.
Hamostaseologie. 2025 Aug 7. doi: 10.1055/a-2645-4927.
2
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry.
Intern Emerg Med. 2025 Jul 30. doi: 10.1007/s11739-025-04054-7.
3
Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6 months of therapy: A narrative review.
Thromb Res. 2025 Sep;253:109403. doi: 10.1016/j.thromres.2025.109403. Epub 2025 Jul 14.
4
Variability in Inferior Vena Cava (IVC) Filter Retrieval Rates and Adherence to Guidelines: A Multi-Center Retrospective Analysis.
J Clin Med. 2025 Jun 7;14(12):4034. doi: 10.3390/jcm14124034.
5
Internal Jugular Vein Thrombosis: A Bicentric Cohort Study.
J Clin Med. 2025 May 22;14(11):3626. doi: 10.3390/jcm14113626.
6
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29.
7
The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity.
J Clin Med. 2025 Mar 12;14(6):1909. doi: 10.3390/jcm14061909.
8
Characteristics and Outcomes of Pulmonary Embolism Patients Transferred After Activation of Pulmonary Embolism Response Team and Admitted from Local Emergency Department.
J Clin Med. 2025 Jan 22;14(3):677. doi: 10.3390/jcm14030677.
9
From Cell Interactions to Bedside Practice: Complete Blood Count-Derived Biomarkers with Diagnostic and Prognostic Potential in Venous Thromboembolism.
J Clin Med. 2025 Jan 2;14(1):205. doi: 10.3390/jcm14010205.
10
Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.
Am Heart J. 2025 Mar;281:112-122. doi: 10.1016/j.ahj.2024.11.016. Epub 2024 Dec 3.
Zotero 插件